Beebe Katherine 4
4 · TITAN PHARMACEUTICALS INC · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Beebe Katherine
Chief Scientific Officer
Transactions
- Award
Option to Purchase Common Stock
2022-01-05+55,000→ 55,000 totalExercise: $1.18Exp: 2032-01-05→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The options vest as to 27,500 shares on July 5, 2022 with the balance to vest in equal monthly installments over the 18 months thereafter.